Related updates
Alphabet (GOOGL) and Meta Platforms (META) are buying into AI biology. On Wednesday, October 7, Google DeepMind, Alphabet’s drug discovery unit Isomorphic Labs, and Meta agreed to put a combined $300 million into Biohub’s Virtual Biology Initiative. Biohub is the science group backed by Mark Zuckerberg and Priscilla Chan. With the U.S. Department of Energy and the National Institutes of Health also in, total commitme
Listen: Solving all disease is one of the most monumentally complex challenges in science. Today, for the first time, AI provides the foundation to make it achievable. Tackling the frontier of human health is our mission, and it means identifying exactly where modern AI can make the greatest difference. We see drug discovery as the critical wedge in solving all disease, and therefore our initial focal point where AI
Google DeepMind said Tuesday that it has used artificial intelligence to predict the biological consequences of all 9 billion possible single-letter changes to human DNA, and is making the resulting database available free to academic researchers worldwide. AlphaGenome Atlas, as DeepMind calls the database, is a precomputed catalogue of what each substitution of a single DNA base is likely to do to the machinery that
Our approach to bioresilience The global biosecurity landscape is rapidly evolving. Shifting natural ecosystems, global travel and the potential misuse of AI require greater vigilance — yet AI is also a critical tool for our response. We need frontier AI models, and the scientific advances they will enable, to respond to these challenges and help make society more resilient to events like future outbreaks. Today, Goo